These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7229835)
21. Standardization of forensic drug analyses. Frank RS; Gunn JW J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386 [No Abstract] [Full Text] [Related]
22. Drug ads. Some mislead consumers. Roberts SS Diabetes Forecast; 2003 Oct; 56(10):46-8. PubMed ID: 15317096 [No Abstract] [Full Text] [Related]
23. The intensified drug inspection program: procedures and results. Clevenger WL Bull Parenter Drug Assoc; 1969; 23(6):263-8. PubMed ID: 5355888 [No Abstract] [Full Text] [Related]
24. Planning for change. Hansen DC Bull Parenter Drug Assoc; 1969; 23(1):1-5. PubMed ID: 5765717 [No Abstract] [Full Text] [Related]
25. Securing the US pharmaceutical supply. Somberg JC Am J Ther; 2008; 15(3):197. PubMed ID: 18496255 [No Abstract] [Full Text] [Related]
26. Toward more effective drug regulation. Schmidt AM FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532 [No Abstract] [Full Text] [Related]
27. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement. Asamoah AK Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035 [No Abstract] [Full Text] [Related]
29. Products in the U.S. pipeline. Pharmaceutical Manufacturers Association. Biotechnology (N Y); 1991 Oct; 9(10):947-9. PubMed ID: 1367805 [No Abstract] [Full Text] [Related]
30. LyphoMed sparks worries. Wagner M Mod Healthc; 1988 Jul; 18(29):5. PubMed ID: 10325202 [No Abstract] [Full Text] [Related]
31. Is the drought over for pharming? Kaiser J Science; 2008 Apr; 320(5875):473-5. PubMed ID: 18436771 [No Abstract] [Full Text] [Related]
32. The meaning of the "me-too" drug decision. Archambault GF Hosp Formul; 1975 Oct; 10(10):510. PubMed ID: 10316671 [No Abstract] [Full Text] [Related]
33. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970. Tobbell DA Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387 [TBL] [Abstract][Full Text] [Related]
34. Institute of Medicine's new drug safety report: implications for Canada. Cassels A CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086 [No Abstract] [Full Text] [Related]
35. Your health in the 21st century. A better safety net. Rosenberg D Newsweek; 2005; 145(26A):70-2. PubMed ID: 16375152 [No Abstract] [Full Text] [Related]
37. Retrospective view of the interfacial relationship of the pharmaceutical industry with the Food and Drug Administration and the United States Pharmacopeia. Hammer HF J Parenter Sci Technol; 1984; 38(4):159-63. PubMed ID: 6491859 [No Abstract] [Full Text] [Related]
38. The drug efficacy study. Provost GP Am J Hosp Pharm; 1968 Sep; 25(9):483. PubMed ID: 5671558 [No Abstract] [Full Text] [Related]
39. Auditing clinical research data: objectives, applications and results. Justice RL Drug Inf J; 1983; 17(1):31-8. PubMed ID: 10262249 [TBL] [Abstract][Full Text] [Related]
40. New drugs: the AMA and the FDA. Appel JZ Ann Allergy; 1966 Jul; 24(7):333-6. PubMed ID: 5941864 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]